详细信息

New thiazole derivative used in pharmaceutical composition for preparing medicine used for treating dihydroorotate dehydrogenase-mediated diseases chosen from autoimmune disease, bacterial infection, parasitic disease, and tumor in subject    

文献类型:专利

英文题名:New thiazole derivative used in pharmaceutical composition for preparing medicine used for treating dihydroorotate dehydrogenase-mediated diseases chosen from autoimmune disease, bacterial infection, parasitic disease, and tumor in subject

作者:LI H;XU Y;WANG R;ZHAO Z;SONG W;XU L

机构:[1]UNIV EAST CHINA SCI & TECHNOLOGY

申请号:WO2017198178-A1

申请日:2017-05-17

公开日:2017-11-23

语种:英文

收录:DERWENT

摘要:NOVELTY - A thiazole derivative (I), is new. USE - New thiazole derivative or its salt or ester is used in pharmaceutical composition for preparing medicine, for treating DHODH-mediated diseases chosen from autoimmune disease, bacterial infection, parasitic disease, and tumor in subject. The autoimmune diseases are chosen from rheumatoid arthritis, organ transplant rejection, and psoriasis (all claimed). DETAILED DESCRIPTION - A thiazole derivative of formula (I), is new. R1=H, optionally substituted 1-6C alkyl or 3-6C cycloalkyl; R2=H, halo, CN, NO2, hydroxy, NR'aR'b, or 1-6C alkyl or 1-6C alkoxy (both optionally substituted); R'a,R'b=H or 1-6C alkyl; R3=H, or optionally substituted 1-6C alkyl; R4=H or halo; m=0-4;and n=0-5. (i) When R2 is H and R3 is H, R1 is not H. An INDEPENDENT CLAIM is included for pharmaceutical composition, which comprises the derivative (I) and a carrier.

参考文献:

正在载入数据...

版权所有©华东理工大学 重庆维普资讯有限公司 渝B2-20050021-7 
渝公网安备 50019002500408号 违法和不良信息举报中心